SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 5 - Annual statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-20-022091
Filing Date
2020-02-14
Accepted
2020-02-14 17:58:19
Documents
2
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm208184-6_form5.html 5  
1 OWNERSHIP DOCUMENT tm208184-6_form5.xml 5 5192
2 EXHIBIT 24 tm208184-6_ex24.htm EX-24 6959
  Complete submission text file 0001104659-20-022091.txt   13746
Mailing Address 4503 GLENCOE AVENUE MARINA DEL REY CA 90292
Business Address 4503 GLENCOE AVENUE MARINA DEL REY CA 90292 310-665-2928
Armata Pharmaceuticals, Inc. (Issuer) CIK: 0000921114 (see all company filings)

IRS No.: 911549568 | State of Incorp.: WA | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O BIOTRANSPLANT INC 196 BOSTON AVE SUITE 2800 MEDFORD MA 02155
Business Address
PERRY MICHAEL S (Reporting) CIK: 0001250379 (see all company filings)

Type: 5 | Act: 34 | File No.: 001-37544 | Film No.: 20622328